Global Radiotheranostic Market Growth (Status and Outlook) 2026-2032
The global Radiotheranostic market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The field of radiotheranostic, which combines diagnostic and therapeutic applications of radiopharmaceuticals, is experiencing growth as it allows for more precise cancer diagnosis and treatment planning. Advances in targeted radiopharmaceuticals and imaging techniques are driving this trend.
LPI (LP Information)' newest research report, the “Radiotheranostic Industry Forecast” looks at past sales and reviews total world Radiotheranostic sales in 2025, providing a comprehensive analysis by region and market sector of projected Radiotheranostic sales for 2026 through 2032. With Radiotheranostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiotheranostic industry.
This Insight Report provides a comprehensive analysis of the global Radiotheranostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Radiotheranostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radiotheranostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiotheranostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiotheranostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiotheranostic market by product type, application, key players and key regions and countries.
Segmentation by Type:
The field of radiotheranostic, which combines diagnostic and therapeutic applications of radiopharmaceuticals, is experiencing growth as it allows for more precise cancer diagnosis and treatment planning. Advances in targeted radiopharmaceuticals and imaging techniques are driving this trend.
LPI (LP Information)' newest research report, the “Radiotheranostic Industry Forecast” looks at past sales and reviews total world Radiotheranostic sales in 2025, providing a comprehensive analysis by region and market sector of projected Radiotheranostic sales for 2026 through 2032. With Radiotheranostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiotheranostic industry.
This Insight Report provides a comprehensive analysis of the global Radiotheranostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Radiotheranostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radiotheranostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiotheranostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiotheranostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiotheranostic market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Nuclear Reactors
- Cyclotrons
- Oncology
- Non-Oncology
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ITM Isotopen Technologien M?nchen AG
- Advanced Accelerator Applications
- Telix Pharmaceuticals
- Theragnostics Ltd.
- NuView Life Sciences
- Jubilant Pharma Limited
- Clarity Pharmaceuticals.
- TransCode Therapeutics, Inc.
- Curium SAS
- GE Healthcare Inc.
- Bayer AG
- Lantheus Medical
- Imaging, Inc.
- Novartis AG
- Spectrum Pharmaceuticals, Inc.
- Ipsen S.A.
- Actinium Pharmaceuticals, Inc. (ATNM)
- Nordic Nanovector ASA
- Y-mAbs Therapeutics, Inc.
- Sofie Biosciences, Inc.
- Terumo Corporation
- Sirtex Medical Limited
- Boston Scientific Corporation
- Nihon Medi-Physics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiotheranostic Market Size (2021-2032)
2.1.2 Radiotheranostic Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Radiotheranostic by Country/Region (2021, 2025 & 2032)
2.2 Radiotheranostic Segment by Type
2.2.1 Nuclear Reactors
2.2.2 Cyclotrons
2.2.3 Radiotheranostic Market Size by Type
2.2.3.1 Radiotheranostic Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Radiotheranostic Market Size Market Share by Type (2021-2026)
2.3 Radiotheranostic Segment by Application
2.3.1 Oncology
2.3.2 Non-Oncology
2.3.3 Radiotheranostic Market Size by Application
2.3.3.1 Radiotheranostic Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Radiotheranostic Market Size Market Share by Application (2021-2026)
3 RADIOTHERANOSTIC MARKET SIZE BY PLAYER
3.1 Radiotheranostic Market Size Market Share by Player
3.1.1 Global Radiotheranostic Revenue by Player (2021-2026)
3.1.2 Global Radiotheranostic Revenue Market Share by Player (2021-2026)
3.2 Global Radiotheranostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RADIOTHERANOSTIC BY REGION
4.1 Radiotheranostic Market Size by Region (2021-2026)
4.2 Global Radiotheranostic Annual Revenue by Country/Region (2021-2026)
4.3 Americas Radiotheranostic Market Size Growth (2021-2026)
4.4 APAC Radiotheranostic Market Size Growth (2021-2026)
4.5 Europe Radiotheranostic Market Size Growth (2021-2026)
4.6 Middle East & Africa Radiotheranostic Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Radiotheranostic Market Size by Country (2021-2026)
5.2 Americas Radiotheranostic Market Size by Type (2021-2026)
5.3 Americas Radiotheranostic Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiotheranostic Market Size by Region (2021-2026)
6.2 APAC Radiotheranostic Market Size by Type (2021-2026)
6.3 APAC Radiotheranostic Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Radiotheranostic Market Size by Country (2021-2026)
7.2 Europe Radiotheranostic Market Size by Type (2021-2026)
7.3 Europe Radiotheranostic Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiotheranostic by Region (2021-2026)
8.2 Middle East & Africa Radiotheranostic Market Size by Type (2021-2026)
8.3 Middle East & Africa Radiotheranostic Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RADIOTHERANOSTIC MARKET FORECAST
10.1 Global Radiotheranostic Forecast by Region (2027-2032)
10.1.1 Global Radiotheranostic Forecast by Region (2027-2032)
10.1.2 Americas Radiotheranostic Forecast
10.1.3 APAC Radiotheranostic Forecast
10.1.4 Europe Radiotheranostic Forecast
10.1.5 Middle East & Africa Radiotheranostic Forecast
10.2 Americas Radiotheranostic Forecast by Country (2027-2032)
10.2.1 United States Market Radiotheranostic Forecast
10.2.2 Canada Market Radiotheranostic Forecast
10.2.3 Mexico Market Radiotheranostic Forecast
10.2.4 Brazil Market Radiotheranostic Forecast
10.3 APAC Radiotheranostic Forecast by Region (2027-2032)
10.3.1 China Radiotheranostic Market Forecast
10.3.2 Japan Market Radiotheranostic Forecast
10.3.3 Korea Market Radiotheranostic Forecast
10.3.4 Southeast Asia Market Radiotheranostic Forecast
10.3.5 India Market Radiotheranostic Forecast
10.3.6 Australia Market Radiotheranostic Forecast
10.4 Europe Radiotheranostic Forecast by Country (2027-2032)
10.4.1 Germany Market Radiotheranostic Forecast
10.4.2 France Market Radiotheranostic Forecast
10.4.3 UK Market Radiotheranostic Forecast
10.4.4 Italy Market Radiotheranostic Forecast
10.4.5 Russia Market Radiotheranostic Forecast
10.5 Middle East & Africa Radiotheranostic Forecast by Region (2027-2032)
10.5.1 Egypt Market Radiotheranostic Forecast
10.5.2 South Africa Market Radiotheranostic Forecast
10.5.3 Israel Market Radiotheranostic Forecast
10.5.4 Turkey Market Radiotheranostic Forecast
10.6 Global Radiotheranostic Forecast by Type (2027-2032)
10.7 Global Radiotheranostic Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Radiotheranostic Forecast
11 KEY PLAYERS ANALYSIS
11.1 ITM Isotopen Technologien M?nchen AG
11.1.1 ITM Isotopen Technologien M?nchen AG Company Information
11.1.2 ITM Isotopen Technologien M?nchen AG Radiotheranostic Product Offered
11.1.3 ITM Isotopen Technologien M?nchen AG Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 ITM Isotopen Technologien M?nchen AG Main Business Overview
11.1.5 ITM Isotopen Technologien M?nchen AG Latest Developments
11.2 Advanced Accelerator Applications
11.2.1 Advanced Accelerator Applications Company Information
11.2.2 Advanced Accelerator Applications Radiotheranostic Product Offered
11.2.3 Advanced Accelerator Applications Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Advanced Accelerator Applications Main Business Overview
11.2.5 Advanced Accelerator Applications Latest Developments
11.3 Telix Pharmaceuticals
11.3.1 Telix Pharmaceuticals Company Information
11.3.2 Telix Pharmaceuticals Radiotheranostic Product Offered
11.3.3 Telix Pharmaceuticals Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Telix Pharmaceuticals Main Business Overview
11.3.5 Telix Pharmaceuticals Latest Developments
11.4 Theragnostics Ltd.
11.4.1 Theragnostics Ltd. Company Information
11.4.2 Theragnostics Ltd. Radiotheranostic Product Offered
11.4.3 Theragnostics Ltd. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Theragnostics Ltd. Main Business Overview
11.4.5 Theragnostics Ltd. Latest Developments
11.5 NuView Life Sciences
11.5.1 NuView Life Sciences Company Information
11.5.2 NuView Life Sciences Radiotheranostic Product Offered
11.5.3 NuView Life Sciences Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 NuView Life Sciences Main Business Overview
11.5.5 NuView Life Sciences Latest Developments
11.6 Jubilant Pharma Limited
11.6.1 Jubilant Pharma Limited Company Information
11.6.2 Jubilant Pharma Limited Radiotheranostic Product Offered
11.6.3 Jubilant Pharma Limited Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Jubilant Pharma Limited Main Business Overview
11.6.5 Jubilant Pharma Limited Latest Developments
11.7 Clarity Pharmaceuticals.
11.7.1 Clarity Pharmaceuticals. Company Information
11.7.2 Clarity Pharmaceuticals. Radiotheranostic Product Offered
11.7.3 Clarity Pharmaceuticals. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Clarity Pharmaceuticals. Main Business Overview
11.7.5 Clarity Pharmaceuticals. Latest Developments
11.8 TransCode Therapeutics, Inc.
11.8.1 TransCode Therapeutics, Inc. Company Information
11.8.2 TransCode Therapeutics, Inc. Radiotheranostic Product Offered
11.8.3 TransCode Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 TransCode Therapeutics, Inc. Main Business Overview
11.8.5 TransCode Therapeutics, Inc. Latest Developments
11.9 Curium SAS
11.9.1 Curium SAS Company Information
11.9.2 Curium SAS Radiotheranostic Product Offered
11.9.3 Curium SAS Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Curium SAS Main Business Overview
11.9.5 Curium SAS Latest Developments
11.10 GE Healthcare Inc.
11.10.1 GE Healthcare Inc. Company Information
11.10.2 GE Healthcare Inc. Radiotheranostic Product Offered
11.10.3 GE Healthcare Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 GE Healthcare Inc. Main Business Overview
11.10.5 GE Healthcare Inc. Latest Developments
11.11 Bayer AG
11.11.1 Bayer AG Company Information
11.11.2 Bayer AG Radiotheranostic Product Offered
11.11.3 Bayer AG Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Bayer AG Main Business Overview
11.11.5 Bayer AG Latest Developments
11.12 Lantheus Medical
11.12.1 Lantheus Medical Company Information
11.12.2 Lantheus Medical Radiotheranostic Product Offered
11.12.3 Lantheus Medical Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Lantheus Medical Main Business Overview
11.12.5 Lantheus Medical Latest Developments
11.13 Imaging, Inc.
11.13.1 Imaging, Inc. Company Information
11.13.2 Imaging, Inc. Radiotheranostic Product Offered
11.13.3 Imaging, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Imaging, Inc. Main Business Overview
11.13.5 Imaging, Inc. Latest Developments
11.14 Novartis AG
11.14.1 Novartis AG Company Information
11.14.2 Novartis AG Radiotheranostic Product Offered
11.14.3 Novartis AG Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Novartis AG Main Business Overview
11.14.5 Novartis AG Latest Developments
11.15 Spectrum Pharmaceuticals, Inc.
11.15.1 Spectrum Pharmaceuticals, Inc. Company Information
11.15.2 Spectrum Pharmaceuticals, Inc. Radiotheranostic Product Offered
11.15.3 Spectrum Pharmaceuticals, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Spectrum Pharmaceuticals, Inc. Main Business Overview
11.15.5 Spectrum Pharmaceuticals, Inc. Latest Developments
11.16 Ipsen S.A.
11.16.1 Ipsen S.A. Company Information
11.16.2 Ipsen S.A. Radiotheranostic Product Offered
11.16.3 Ipsen S.A. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Ipsen S.A. Main Business Overview
11.16.5 Ipsen S.A. Latest Developments
11.17 Actinium Pharmaceuticals, Inc. (ATNM)
11.17.1 Actinium Pharmaceuticals, Inc. (ATNM) Company Information
11.17.2 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product Offered
11.17.3 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Actinium Pharmaceuticals, Inc. (ATNM) Main Business Overview
11.17.5 Actinium Pharmaceuticals, Inc. (ATNM) Latest Developments
11.18 Nordic Nanovector ASA
11.18.1 Nordic Nanovector ASA Company Information
11.18.2 Nordic Nanovector ASA Radiotheranostic Product Offered
11.18.3 Nordic Nanovector ASA Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Nordic Nanovector ASA Main Business Overview
11.18.5 Nordic Nanovector ASA Latest Developments
11.19 Y-mAbs Therapeutics, Inc.
11.19.1 Y-mAbs Therapeutics, Inc. Company Information
11.19.2 Y-mAbs Therapeutics, Inc. Radiotheranostic Product Offered
11.19.3 Y-mAbs Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Y-mAbs Therapeutics, Inc. Main Business Overview
11.19.5 Y-mAbs Therapeutics, Inc. Latest Developments
11.20 Sofie Biosciences, Inc.
11.20.1 Sofie Biosciences, Inc. Company Information
11.20.2 Sofie Biosciences, Inc. Radiotheranostic Product Offered
11.20.3 Sofie Biosciences, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Sofie Biosciences, Inc. Main Business Overview
11.20.5 Sofie Biosciences, Inc. Latest Developments
11.21 Terumo Corporation
11.21.1 Terumo Corporation Company Information
11.21.2 Terumo Corporation Radiotheranostic Product Offered
11.21.3 Terumo Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Terumo Corporation Main Business Overview
11.21.5 Terumo Corporation Latest Developments
11.22 Sirtex Medical Limited
11.22.1 Sirtex Medical Limited Company Information
11.22.2 Sirtex Medical Limited Radiotheranostic Product Offered
11.22.3 Sirtex Medical Limited Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Sirtex Medical Limited Main Business Overview
11.22.5 Sirtex Medical Limited Latest Developments
11.23 Boston Scientific Corporation
11.23.1 Boston Scientific Corporation Company Information
11.23.2 Boston Scientific Corporation Radiotheranostic Product Offered
11.23.3 Boston Scientific Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Boston Scientific Corporation Main Business Overview
11.23.5 Boston Scientific Corporation Latest Developments
11.24 Nihon Medi-Physics
11.24.1 Nihon Medi-Physics Company Information
11.24.2 Nihon Medi-Physics Radiotheranostic Product Offered
11.24.3 Nihon Medi-Physics Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Nihon Medi-Physics Main Business Overview
11.24.5 Nihon Medi-Physics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiotheranostic Market Size (2021-2032)
2.1.2 Radiotheranostic Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Radiotheranostic by Country/Region (2021, 2025 & 2032)
2.2 Radiotheranostic Segment by Type
2.2.1 Nuclear Reactors
2.2.2 Cyclotrons
2.2.3 Radiotheranostic Market Size by Type
2.2.3.1 Radiotheranostic Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Radiotheranostic Market Size Market Share by Type (2021-2026)
2.3 Radiotheranostic Segment by Application
2.3.1 Oncology
2.3.2 Non-Oncology
2.3.3 Radiotheranostic Market Size by Application
2.3.3.1 Radiotheranostic Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Radiotheranostic Market Size Market Share by Application (2021-2026)
3 RADIOTHERANOSTIC MARKET SIZE BY PLAYER
3.1 Radiotheranostic Market Size Market Share by Player
3.1.1 Global Radiotheranostic Revenue by Player (2021-2026)
3.1.2 Global Radiotheranostic Revenue Market Share by Player (2021-2026)
3.2 Global Radiotheranostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RADIOTHERANOSTIC BY REGION
4.1 Radiotheranostic Market Size by Region (2021-2026)
4.2 Global Radiotheranostic Annual Revenue by Country/Region (2021-2026)
4.3 Americas Radiotheranostic Market Size Growth (2021-2026)
4.4 APAC Radiotheranostic Market Size Growth (2021-2026)
4.5 Europe Radiotheranostic Market Size Growth (2021-2026)
4.6 Middle East & Africa Radiotheranostic Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Radiotheranostic Market Size by Country (2021-2026)
5.2 Americas Radiotheranostic Market Size by Type (2021-2026)
5.3 Americas Radiotheranostic Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiotheranostic Market Size by Region (2021-2026)
6.2 APAC Radiotheranostic Market Size by Type (2021-2026)
6.3 APAC Radiotheranostic Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Radiotheranostic Market Size by Country (2021-2026)
7.2 Europe Radiotheranostic Market Size by Type (2021-2026)
7.3 Europe Radiotheranostic Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiotheranostic by Region (2021-2026)
8.2 Middle East & Africa Radiotheranostic Market Size by Type (2021-2026)
8.3 Middle East & Africa Radiotheranostic Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RADIOTHERANOSTIC MARKET FORECAST
10.1 Global Radiotheranostic Forecast by Region (2027-2032)
10.1.1 Global Radiotheranostic Forecast by Region (2027-2032)
10.1.2 Americas Radiotheranostic Forecast
10.1.3 APAC Radiotheranostic Forecast
10.1.4 Europe Radiotheranostic Forecast
10.1.5 Middle East & Africa Radiotheranostic Forecast
10.2 Americas Radiotheranostic Forecast by Country (2027-2032)
10.2.1 United States Market Radiotheranostic Forecast
10.2.2 Canada Market Radiotheranostic Forecast
10.2.3 Mexico Market Radiotheranostic Forecast
10.2.4 Brazil Market Radiotheranostic Forecast
10.3 APAC Radiotheranostic Forecast by Region (2027-2032)
10.3.1 China Radiotheranostic Market Forecast
10.3.2 Japan Market Radiotheranostic Forecast
10.3.3 Korea Market Radiotheranostic Forecast
10.3.4 Southeast Asia Market Radiotheranostic Forecast
10.3.5 India Market Radiotheranostic Forecast
10.3.6 Australia Market Radiotheranostic Forecast
10.4 Europe Radiotheranostic Forecast by Country (2027-2032)
10.4.1 Germany Market Radiotheranostic Forecast
10.4.2 France Market Radiotheranostic Forecast
10.4.3 UK Market Radiotheranostic Forecast
10.4.4 Italy Market Radiotheranostic Forecast
10.4.5 Russia Market Radiotheranostic Forecast
10.5 Middle East & Africa Radiotheranostic Forecast by Region (2027-2032)
10.5.1 Egypt Market Radiotheranostic Forecast
10.5.2 South Africa Market Radiotheranostic Forecast
10.5.3 Israel Market Radiotheranostic Forecast
10.5.4 Turkey Market Radiotheranostic Forecast
10.6 Global Radiotheranostic Forecast by Type (2027-2032)
10.7 Global Radiotheranostic Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Radiotheranostic Forecast
11 KEY PLAYERS ANALYSIS
11.1 ITM Isotopen Technologien M?nchen AG
11.1.1 ITM Isotopen Technologien M?nchen AG Company Information
11.1.2 ITM Isotopen Technologien M?nchen AG Radiotheranostic Product Offered
11.1.3 ITM Isotopen Technologien M?nchen AG Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 ITM Isotopen Technologien M?nchen AG Main Business Overview
11.1.5 ITM Isotopen Technologien M?nchen AG Latest Developments
11.2 Advanced Accelerator Applications
11.2.1 Advanced Accelerator Applications Company Information
11.2.2 Advanced Accelerator Applications Radiotheranostic Product Offered
11.2.3 Advanced Accelerator Applications Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Advanced Accelerator Applications Main Business Overview
11.2.5 Advanced Accelerator Applications Latest Developments
11.3 Telix Pharmaceuticals
11.3.1 Telix Pharmaceuticals Company Information
11.3.2 Telix Pharmaceuticals Radiotheranostic Product Offered
11.3.3 Telix Pharmaceuticals Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Telix Pharmaceuticals Main Business Overview
11.3.5 Telix Pharmaceuticals Latest Developments
11.4 Theragnostics Ltd.
11.4.1 Theragnostics Ltd. Company Information
11.4.2 Theragnostics Ltd. Radiotheranostic Product Offered
11.4.3 Theragnostics Ltd. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Theragnostics Ltd. Main Business Overview
11.4.5 Theragnostics Ltd. Latest Developments
11.5 NuView Life Sciences
11.5.1 NuView Life Sciences Company Information
11.5.2 NuView Life Sciences Radiotheranostic Product Offered
11.5.3 NuView Life Sciences Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 NuView Life Sciences Main Business Overview
11.5.5 NuView Life Sciences Latest Developments
11.6 Jubilant Pharma Limited
11.6.1 Jubilant Pharma Limited Company Information
11.6.2 Jubilant Pharma Limited Radiotheranostic Product Offered
11.6.3 Jubilant Pharma Limited Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Jubilant Pharma Limited Main Business Overview
11.6.5 Jubilant Pharma Limited Latest Developments
11.7 Clarity Pharmaceuticals.
11.7.1 Clarity Pharmaceuticals. Company Information
11.7.2 Clarity Pharmaceuticals. Radiotheranostic Product Offered
11.7.3 Clarity Pharmaceuticals. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Clarity Pharmaceuticals. Main Business Overview
11.7.5 Clarity Pharmaceuticals. Latest Developments
11.8 TransCode Therapeutics, Inc.
11.8.1 TransCode Therapeutics, Inc. Company Information
11.8.2 TransCode Therapeutics, Inc. Radiotheranostic Product Offered
11.8.3 TransCode Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 TransCode Therapeutics, Inc. Main Business Overview
11.8.5 TransCode Therapeutics, Inc. Latest Developments
11.9 Curium SAS
11.9.1 Curium SAS Company Information
11.9.2 Curium SAS Radiotheranostic Product Offered
11.9.3 Curium SAS Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Curium SAS Main Business Overview
11.9.5 Curium SAS Latest Developments
11.10 GE Healthcare Inc.
11.10.1 GE Healthcare Inc. Company Information
11.10.2 GE Healthcare Inc. Radiotheranostic Product Offered
11.10.3 GE Healthcare Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 GE Healthcare Inc. Main Business Overview
11.10.5 GE Healthcare Inc. Latest Developments
11.11 Bayer AG
11.11.1 Bayer AG Company Information
11.11.2 Bayer AG Radiotheranostic Product Offered
11.11.3 Bayer AG Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Bayer AG Main Business Overview
11.11.5 Bayer AG Latest Developments
11.12 Lantheus Medical
11.12.1 Lantheus Medical Company Information
11.12.2 Lantheus Medical Radiotheranostic Product Offered
11.12.3 Lantheus Medical Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Lantheus Medical Main Business Overview
11.12.5 Lantheus Medical Latest Developments
11.13 Imaging, Inc.
11.13.1 Imaging, Inc. Company Information
11.13.2 Imaging, Inc. Radiotheranostic Product Offered
11.13.3 Imaging, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Imaging, Inc. Main Business Overview
11.13.5 Imaging, Inc. Latest Developments
11.14 Novartis AG
11.14.1 Novartis AG Company Information
11.14.2 Novartis AG Radiotheranostic Product Offered
11.14.3 Novartis AG Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Novartis AG Main Business Overview
11.14.5 Novartis AG Latest Developments
11.15 Spectrum Pharmaceuticals, Inc.
11.15.1 Spectrum Pharmaceuticals, Inc. Company Information
11.15.2 Spectrum Pharmaceuticals, Inc. Radiotheranostic Product Offered
11.15.3 Spectrum Pharmaceuticals, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Spectrum Pharmaceuticals, Inc. Main Business Overview
11.15.5 Spectrum Pharmaceuticals, Inc. Latest Developments
11.16 Ipsen S.A.
11.16.1 Ipsen S.A. Company Information
11.16.2 Ipsen S.A. Radiotheranostic Product Offered
11.16.3 Ipsen S.A. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Ipsen S.A. Main Business Overview
11.16.5 Ipsen S.A. Latest Developments
11.17 Actinium Pharmaceuticals, Inc. (ATNM)
11.17.1 Actinium Pharmaceuticals, Inc. (ATNM) Company Information
11.17.2 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product Offered
11.17.3 Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Actinium Pharmaceuticals, Inc. (ATNM) Main Business Overview
11.17.5 Actinium Pharmaceuticals, Inc. (ATNM) Latest Developments
11.18 Nordic Nanovector ASA
11.18.1 Nordic Nanovector ASA Company Information
11.18.2 Nordic Nanovector ASA Radiotheranostic Product Offered
11.18.3 Nordic Nanovector ASA Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Nordic Nanovector ASA Main Business Overview
11.18.5 Nordic Nanovector ASA Latest Developments
11.19 Y-mAbs Therapeutics, Inc.
11.19.1 Y-mAbs Therapeutics, Inc. Company Information
11.19.2 Y-mAbs Therapeutics, Inc. Radiotheranostic Product Offered
11.19.3 Y-mAbs Therapeutics, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Y-mAbs Therapeutics, Inc. Main Business Overview
11.19.5 Y-mAbs Therapeutics, Inc. Latest Developments
11.20 Sofie Biosciences, Inc.
11.20.1 Sofie Biosciences, Inc. Company Information
11.20.2 Sofie Biosciences, Inc. Radiotheranostic Product Offered
11.20.3 Sofie Biosciences, Inc. Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Sofie Biosciences, Inc. Main Business Overview
11.20.5 Sofie Biosciences, Inc. Latest Developments
11.21 Terumo Corporation
11.21.1 Terumo Corporation Company Information
11.21.2 Terumo Corporation Radiotheranostic Product Offered
11.21.3 Terumo Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Terumo Corporation Main Business Overview
11.21.5 Terumo Corporation Latest Developments
11.22 Sirtex Medical Limited
11.22.1 Sirtex Medical Limited Company Information
11.22.2 Sirtex Medical Limited Radiotheranostic Product Offered
11.22.3 Sirtex Medical Limited Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Sirtex Medical Limited Main Business Overview
11.22.5 Sirtex Medical Limited Latest Developments
11.23 Boston Scientific Corporation
11.23.1 Boston Scientific Corporation Company Information
11.23.2 Boston Scientific Corporation Radiotheranostic Product Offered
11.23.3 Boston Scientific Corporation Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Boston Scientific Corporation Main Business Overview
11.23.5 Boston Scientific Corporation Latest Developments
11.24 Nihon Medi-Physics
11.24.1 Nihon Medi-Physics Company Information
11.24.2 Nihon Medi-Physics Radiotheranostic Product Offered
11.24.3 Nihon Medi-Physics Radiotheranostic Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Nihon Medi-Physics Main Business Overview
11.24.5 Nihon Medi-Physics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Radiotheranostic Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Radiotheranostic Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Nuclear Reactors
Table 4. Major Players of Cyclotrons
Table 5. Radiotheranostic Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Radiotheranostic Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Radiotheranostic Market Size Market Share by Type (2021-2026)
Table 8. Radiotheranostic Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Radiotheranostic Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Radiotheranostic Market Size Market Share by Application (2021-2026)
Table 11. Global Radiotheranostic Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Radiotheranostic Revenue Market Share by Player (2021-2026)
Table 13. Radiotheranostic Key Players Head office and Products Offered
Table 14. Radiotheranostic Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Radiotheranostic Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Radiotheranostic Market Size Market Share by Region (2021-2026)
Table 19. Global Radiotheranostic Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Radiotheranostic Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Radiotheranostic Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Radiotheranostic Market Size Market Share by Country (2021-2026)
Table 23. Americas Radiotheranostic Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Radiotheranostic Market Size Market Share by Type (2021-2026)
Table 25. Americas Radiotheranostic Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Radiotheranostic Market Size Market Share by Application (2021-2026)
Table 27. APAC Radiotheranostic Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Radiotheranostic Market Size Market Share by Region (2021-2026)
Table 29. APAC Radiotheranostic Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Radiotheranostic Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Radiotheranostic Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Radiotheranostic Market Size Market Share by Country (2021-2026)
Table 33. Europe Radiotheranostic Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Radiotheranostic Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Radiotheranostic Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Radiotheranostic Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Radiotheranostic Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Radiotheranostic
Table 39. Key Market Challenges & Risks of Radiotheranostic
Table 40. Key Industry Trends of Radiotheranostic
Table 41. Global Radiotheranostic Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Radiotheranostic Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Radiotheranostic Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Radiotheranostic Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. ITM Isotopen Technologien M?nchen AG Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 46. ITM Isotopen Technologien M?nchen AG Radiotheranostic Product Offered
Table 47. ITM Isotopen Technologien M?nchen AG Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. ITM Isotopen Technologien M?nchen AG Main Business
Table 49. ITM Isotopen Technologien M?nchen AG Latest Developments
Table 50. Advanced Accelerator Applications Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 51. Advanced Accelerator Applications Radiotheranostic Product Offered
Table 52. Advanced Accelerator Applications Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Advanced Accelerator Applications Main Business
Table 54. Advanced Accelerator Applications Latest Developments
Table 55. Telix Pharmaceuticals Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 56. Telix Pharmaceuticals Radiotheranostic Product Offered
Table 57. Telix Pharmaceuticals Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Telix Pharmaceuticals Main Business
Table 59. Telix Pharmaceuticals Latest Developments
Table 60. Theragnostics Ltd. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 61. Theragnostics Ltd. Radiotheranostic Product Offered
Table 62. Theragnostics Ltd. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Theragnostics Ltd. Main Business
Table 64. Theragnostics Ltd. Latest Developments
Table 65. NuView Life Sciences Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 66. NuView Life Sciences Radiotheranostic Product Offered
Table 67. NuView Life Sciences Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. NuView Life Sciences Main Business
Table 69. NuView Life Sciences Latest Developments
Table 70. Jubilant Pharma Limited Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 71. Jubilant Pharma Limited Radiotheranostic Product Offered
Table 72. Jubilant Pharma Limited Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Jubilant Pharma Limited Main Business
Table 74. Jubilant Pharma Limited Latest Developments
Table 75. Clarity Pharmaceuticals. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 76. Clarity Pharmaceuticals. Radiotheranostic Product Offered
Table 77. Clarity Pharmaceuticals. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Clarity Pharmaceuticals. Main Business
Table 79. Clarity Pharmaceuticals. Latest Developments
Table 80. TransCode Therapeutics, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 81. TransCode Therapeutics, Inc. Radiotheranostic Product Offered
Table 82. TransCode Therapeutics, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. TransCode Therapeutics, Inc. Main Business
Table 84. TransCode Therapeutics, Inc. Latest Developments
Table 85. Curium SAS Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 86. Curium SAS Radiotheranostic Product Offered
Table 87. Curium SAS Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Curium SAS Main Business
Table 89. Curium SAS Latest Developments
Table 90. GE Healthcare Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 91. GE Healthcare Inc. Radiotheranostic Product Offered
Table 92. GE Healthcare Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. GE Healthcare Inc. Main Business
Table 94. GE Healthcare Inc. Latest Developments
Table 95. Bayer AG Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 96. Bayer AG Radiotheranostic Product Offered
Table 97. Bayer AG Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Bayer AG Main Business
Table 99. Bayer AG Latest Developments
Table 100. Lantheus Medical Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 101. Lantheus Medical Radiotheranostic Product Offered
Table 102. Lantheus Medical Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Lantheus Medical Main Business
Table 104. Lantheus Medical Latest Developments
Table 105. Imaging, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 106. Imaging, Inc. Radiotheranostic Product Offered
Table 107. Imaging, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Imaging, Inc. Main Business
Table 109. Imaging, Inc. Latest Developments
Table 110. Novartis AG Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 111. Novartis AG Radiotheranostic Product Offered
Table 112. Novartis AG Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Novartis AG Main Business
Table 114. Novartis AG Latest Developments
Table 115. Spectrum Pharmaceuticals, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 116. Spectrum Pharmaceuticals, Inc. Radiotheranostic Product Offered
Table 117. Spectrum Pharmaceuticals, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Spectrum Pharmaceuticals, Inc. Main Business
Table 119. Spectrum Pharmaceuticals, Inc. Latest Developments
Table 120. Ipsen S.A. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 121. Ipsen S.A. Radiotheranostic Product Offered
Table 122. Ipsen S.A. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Ipsen S.A. Main Business
Table 124. Ipsen S.A. Latest Developments
Table 125. Actinium Pharmaceuticals, Inc. (ATNM) Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 126. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product Offered
Table 127. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Actinium Pharmaceuticals, Inc. (ATNM) Main Business
Table 129. Actinium Pharmaceuticals, Inc. (ATNM) Latest Developments
Table 130. Nordic Nanovector ASA Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 131. Nordic Nanovector ASA Radiotheranostic Product Offered
Table 132. Nordic Nanovector ASA Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Nordic Nanovector ASA Main Business
Table 134. Nordic Nanovector ASA Latest Developments
Table 135. Y-mAbs Therapeutics, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 136. Y-mAbs Therapeutics, Inc. Radiotheranostic Product Offered
Table 137. Y-mAbs Therapeutics, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Y-mAbs Therapeutics, Inc. Main Business
Table 139. Y-mAbs Therapeutics, Inc. Latest Developments
Table 140. Sofie Biosciences, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 141. Sofie Biosciences, Inc. Radiotheranostic Product Offered
Table 142. Sofie Biosciences, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Sofie Biosciences, Inc. Main Business
Table 144. Sofie Biosciences, Inc. Latest Developments
Table 145. Terumo Corporation Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 146. Terumo Corporation Radiotheranostic Product Offered
Table 147. Terumo Corporation Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Terumo Corporation Main Business
Table 149. Terumo Corporation Latest Developments
Table 150. Sirtex Medical Limited Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 151. Sirtex Medical Limited Radiotheranostic Product Offered
Table 152. Sirtex Medical Limited Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. Sirtex Medical Limited Main Business
Table 154. Sirtex Medical Limited Latest Developments
Table 155. Boston Scientific Corporation Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 156. Boston Scientific Corporation Radiotheranostic Product Offered
Table 157. Boston Scientific Corporation Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. Boston Scientific Corporation Main Business
Table 159. Boston Scientific Corporation Latest Developments
Table 160. Nihon Medi-Physics Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 161. Nihon Medi-Physics Radiotheranostic Product Offered
Table 162. Nihon Medi-Physics Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. Nihon Medi-Physics Main Business
Table 164. Nihon Medi-Physics Latest Developments
Table 1. Radiotheranostic Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Radiotheranostic Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Nuclear Reactors
Table 4. Major Players of Cyclotrons
Table 5. Radiotheranostic Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Radiotheranostic Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Radiotheranostic Market Size Market Share by Type (2021-2026)
Table 8. Radiotheranostic Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Radiotheranostic Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Radiotheranostic Market Size Market Share by Application (2021-2026)
Table 11. Global Radiotheranostic Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Radiotheranostic Revenue Market Share by Player (2021-2026)
Table 13. Radiotheranostic Key Players Head office and Products Offered
Table 14. Radiotheranostic Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Radiotheranostic Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Radiotheranostic Market Size Market Share by Region (2021-2026)
Table 19. Global Radiotheranostic Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Radiotheranostic Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Radiotheranostic Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Radiotheranostic Market Size Market Share by Country (2021-2026)
Table 23. Americas Radiotheranostic Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Radiotheranostic Market Size Market Share by Type (2021-2026)
Table 25. Americas Radiotheranostic Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Radiotheranostic Market Size Market Share by Application (2021-2026)
Table 27. APAC Radiotheranostic Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Radiotheranostic Market Size Market Share by Region (2021-2026)
Table 29. APAC Radiotheranostic Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Radiotheranostic Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Radiotheranostic Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Radiotheranostic Market Size Market Share by Country (2021-2026)
Table 33. Europe Radiotheranostic Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Radiotheranostic Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Radiotheranostic Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Radiotheranostic Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Radiotheranostic Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Radiotheranostic
Table 39. Key Market Challenges & Risks of Radiotheranostic
Table 40. Key Industry Trends of Radiotheranostic
Table 41. Global Radiotheranostic Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Radiotheranostic Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Radiotheranostic Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Radiotheranostic Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. ITM Isotopen Technologien M?nchen AG Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 46. ITM Isotopen Technologien M?nchen AG Radiotheranostic Product Offered
Table 47. ITM Isotopen Technologien M?nchen AG Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. ITM Isotopen Technologien M?nchen AG Main Business
Table 49. ITM Isotopen Technologien M?nchen AG Latest Developments
Table 50. Advanced Accelerator Applications Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 51. Advanced Accelerator Applications Radiotheranostic Product Offered
Table 52. Advanced Accelerator Applications Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Advanced Accelerator Applications Main Business
Table 54. Advanced Accelerator Applications Latest Developments
Table 55. Telix Pharmaceuticals Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 56. Telix Pharmaceuticals Radiotheranostic Product Offered
Table 57. Telix Pharmaceuticals Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Telix Pharmaceuticals Main Business
Table 59. Telix Pharmaceuticals Latest Developments
Table 60. Theragnostics Ltd. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 61. Theragnostics Ltd. Radiotheranostic Product Offered
Table 62. Theragnostics Ltd. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Theragnostics Ltd. Main Business
Table 64. Theragnostics Ltd. Latest Developments
Table 65. NuView Life Sciences Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 66. NuView Life Sciences Radiotheranostic Product Offered
Table 67. NuView Life Sciences Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. NuView Life Sciences Main Business
Table 69. NuView Life Sciences Latest Developments
Table 70. Jubilant Pharma Limited Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 71. Jubilant Pharma Limited Radiotheranostic Product Offered
Table 72. Jubilant Pharma Limited Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Jubilant Pharma Limited Main Business
Table 74. Jubilant Pharma Limited Latest Developments
Table 75. Clarity Pharmaceuticals. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 76. Clarity Pharmaceuticals. Radiotheranostic Product Offered
Table 77. Clarity Pharmaceuticals. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Clarity Pharmaceuticals. Main Business
Table 79. Clarity Pharmaceuticals. Latest Developments
Table 80. TransCode Therapeutics, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 81. TransCode Therapeutics, Inc. Radiotheranostic Product Offered
Table 82. TransCode Therapeutics, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. TransCode Therapeutics, Inc. Main Business
Table 84. TransCode Therapeutics, Inc. Latest Developments
Table 85. Curium SAS Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 86. Curium SAS Radiotheranostic Product Offered
Table 87. Curium SAS Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Curium SAS Main Business
Table 89. Curium SAS Latest Developments
Table 90. GE Healthcare Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 91. GE Healthcare Inc. Radiotheranostic Product Offered
Table 92. GE Healthcare Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. GE Healthcare Inc. Main Business
Table 94. GE Healthcare Inc. Latest Developments
Table 95. Bayer AG Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 96. Bayer AG Radiotheranostic Product Offered
Table 97. Bayer AG Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Bayer AG Main Business
Table 99. Bayer AG Latest Developments
Table 100. Lantheus Medical Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 101. Lantheus Medical Radiotheranostic Product Offered
Table 102. Lantheus Medical Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Lantheus Medical Main Business
Table 104. Lantheus Medical Latest Developments
Table 105. Imaging, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 106. Imaging, Inc. Radiotheranostic Product Offered
Table 107. Imaging, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Imaging, Inc. Main Business
Table 109. Imaging, Inc. Latest Developments
Table 110. Novartis AG Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 111. Novartis AG Radiotheranostic Product Offered
Table 112. Novartis AG Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Novartis AG Main Business
Table 114. Novartis AG Latest Developments
Table 115. Spectrum Pharmaceuticals, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 116. Spectrum Pharmaceuticals, Inc. Radiotheranostic Product Offered
Table 117. Spectrum Pharmaceuticals, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Spectrum Pharmaceuticals, Inc. Main Business
Table 119. Spectrum Pharmaceuticals, Inc. Latest Developments
Table 120. Ipsen S.A. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 121. Ipsen S.A. Radiotheranostic Product Offered
Table 122. Ipsen S.A. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Ipsen S.A. Main Business
Table 124. Ipsen S.A. Latest Developments
Table 125. Actinium Pharmaceuticals, Inc. (ATNM) Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 126. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product Offered
Table 127. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Actinium Pharmaceuticals, Inc. (ATNM) Main Business
Table 129. Actinium Pharmaceuticals, Inc. (ATNM) Latest Developments
Table 130. Nordic Nanovector ASA Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 131. Nordic Nanovector ASA Radiotheranostic Product Offered
Table 132. Nordic Nanovector ASA Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Nordic Nanovector ASA Main Business
Table 134. Nordic Nanovector ASA Latest Developments
Table 135. Y-mAbs Therapeutics, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 136. Y-mAbs Therapeutics, Inc. Radiotheranostic Product Offered
Table 137. Y-mAbs Therapeutics, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Y-mAbs Therapeutics, Inc. Main Business
Table 139. Y-mAbs Therapeutics, Inc. Latest Developments
Table 140. Sofie Biosciences, Inc. Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 141. Sofie Biosciences, Inc. Radiotheranostic Product Offered
Table 142. Sofie Biosciences, Inc. Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Sofie Biosciences, Inc. Main Business
Table 144. Sofie Biosciences, Inc. Latest Developments
Table 145. Terumo Corporation Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 146. Terumo Corporation Radiotheranostic Product Offered
Table 147. Terumo Corporation Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Terumo Corporation Main Business
Table 149. Terumo Corporation Latest Developments
Table 150. Sirtex Medical Limited Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 151. Sirtex Medical Limited Radiotheranostic Product Offered
Table 152. Sirtex Medical Limited Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. Sirtex Medical Limited Main Business
Table 154. Sirtex Medical Limited Latest Developments
Table 155. Boston Scientific Corporation Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 156. Boston Scientific Corporation Radiotheranostic Product Offered
Table 157. Boston Scientific Corporation Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. Boston Scientific Corporation Main Business
Table 159. Boston Scientific Corporation Latest Developments
Table 160. Nihon Medi-Physics Details, Company Type, Radiotheranostic Area Served and Its Competitors
Table 161. Nihon Medi-Physics Radiotheranostic Product Offered
Table 162. Nihon Medi-Physics Radiotheranostic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. Nihon Medi-Physics Main Business
Table 164. Nihon Medi-Physics Latest Developments
LIST OF FIGURES
Figure 1. Radiotheranostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radiotheranostic Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Radiotheranostic Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Radiotheranostic Sales Market Share by Country/Region (2025)
Figure 8. Radiotheranostic Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Radiotheranostic Market Size Market Share by Type in 2025
Figure 10. Radiotheranostic in Oncology
Figure 11. Global Radiotheranostic Market: Oncology (2021-2026) & ($ millions)
Figure 12. Radiotheranostic in Non-Oncology
Figure 13. Global Radiotheranostic Market: Non-Oncology (2021-2026) & ($ millions)
Figure 14. Global Radiotheranostic Market Size Market Share by Application in 2025
Figure 15. Global Radiotheranostic Revenue Market Share by Player in 2025
Figure 16. Global Radiotheranostic Market Size Market Share by Region (2021-2026)
Figure 17. Americas Radiotheranostic Market Size 2021-2026 ($ millions)
Figure 18. APAC Radiotheranostic Market Size 2021-2026 ($ millions)
Figure 19. Europe Radiotheranostic Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Radiotheranostic Market Size 2021-2026 ($ millions)
Figure 21. Americas Radiotheranostic Value Market Share by Country in 2025
Figure 22. United States Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Radiotheranostic Market Size Market Share by Region in 2025
Figure 27. APAC Radiotheranostic Market Size Market Share by Type (2021-2026)
Figure 28. APAC Radiotheranostic Market Size Market Share by Application (2021-2026)
Figure 29. China Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 33. India Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Radiotheranostic Market Size Market Share by Country in 2025
Figure 36. Europe Radiotheranostic Market Size Market Share by Type (2021-2026)
Figure 37. Europe Radiotheranostic Market Size Market Share by Application (2021-2026)
Figure 38. Germany Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 39. France Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Radiotheranostic Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Radiotheranostic Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Radiotheranostic Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 52. APAC Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 53. Europe Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 55. United States Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 56. Canada Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 57. Mexico Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 58. Brazil Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 59. China Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 60. Japan Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 61. Korea Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 63. India Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 64. Australia Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 65. Germany Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 66. France Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 67. UK Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 68. Italy Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 69. Russia Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 70. Egypt Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 71. South Africa Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 72. Israel Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 73. Turkey Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 74. Global Radiotheranostic Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Radiotheranostic Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 1. Radiotheranostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radiotheranostic Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Radiotheranostic Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Radiotheranostic Sales Market Share by Country/Region (2025)
Figure 8. Radiotheranostic Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Radiotheranostic Market Size Market Share by Type in 2025
Figure 10. Radiotheranostic in Oncology
Figure 11. Global Radiotheranostic Market: Oncology (2021-2026) & ($ millions)
Figure 12. Radiotheranostic in Non-Oncology
Figure 13. Global Radiotheranostic Market: Non-Oncology (2021-2026) & ($ millions)
Figure 14. Global Radiotheranostic Market Size Market Share by Application in 2025
Figure 15. Global Radiotheranostic Revenue Market Share by Player in 2025
Figure 16. Global Radiotheranostic Market Size Market Share by Region (2021-2026)
Figure 17. Americas Radiotheranostic Market Size 2021-2026 ($ millions)
Figure 18. APAC Radiotheranostic Market Size 2021-2026 ($ millions)
Figure 19. Europe Radiotheranostic Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Radiotheranostic Market Size 2021-2026 ($ millions)
Figure 21. Americas Radiotheranostic Value Market Share by Country in 2025
Figure 22. United States Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Radiotheranostic Market Size Market Share by Region in 2025
Figure 27. APAC Radiotheranostic Market Size Market Share by Type (2021-2026)
Figure 28. APAC Radiotheranostic Market Size Market Share by Application (2021-2026)
Figure 29. China Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 33. India Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Radiotheranostic Market Size Market Share by Country in 2025
Figure 36. Europe Radiotheranostic Market Size Market Share by Type (2021-2026)
Figure 37. Europe Radiotheranostic Market Size Market Share by Application (2021-2026)
Figure 38. Germany Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 39. France Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Radiotheranostic Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Radiotheranostic Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Radiotheranostic Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Radiotheranostic Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 52. APAC Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 53. Europe Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 55. United States Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 56. Canada Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 57. Mexico Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 58. Brazil Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 59. China Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 60. Japan Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 61. Korea Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 63. India Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 64. Australia Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 65. Germany Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 66. France Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 67. UK Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 68. Italy Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 69. Russia Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 70. Egypt Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 71. South Africa Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 72. Israel Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 73. Turkey Radiotheranostic Market Size 2027-2032 ($ millions)
Figure 74. Global Radiotheranostic Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Radiotheranostic Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Radiotheranostic Market Size 2027-2032 ($ millions)
